Prosecution Insights
Last updated: April 19, 2026

Wave Life Sciences Ltd.

7 pending office actions

Portfolio Summary

7
Total Pending OAs
2
Final Rejections
5
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18313032 CHIRAL CONTROL BAKSHI, PANCHAM 1623 Non-Final OA May 05, 2023
18174127 IMMUNOASSAYS FOR DETECTING WILD TYPE HUNTINGTIN PROTEIN AND METHODS OF TREATMENT EMPLOYING SUCH IMMUNOASSAYS CESARE, JOSEPH DAVID 1675 Non-Final OA Feb 24, 2023
18022509 CELLS AND NON-HUMAN ANIMALS ENGINEERED TO EXPRESS ADAR1 AND USES THEREOF WILSON, MICHAEL C 1638 Non-Final OA Feb 21, 2023
17956741 OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF SHIN, DANA H 1635 Final Rejection Sep 29, 2022
17881956 COMPOSITIONS AND METHODS FOR PHOSPHORAMIDITE AND OLIGONUCLEOTIDE SYNTHESIS CRAIGO, BAHAR ALAWI 1699 Non-Final OA Aug 05, 2022
17605998 OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF TRAN, CHRISTINA L 1637 Final Rejection Oct 22, 2021
17426511 OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF TRAN, CHRISTINA L 1637 Non-Final OA Jul 28, 2021

Managing Wave Life Sciences Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month